ENVB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Enveric Biosciences Inc (ENVB) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock lacks significant positive catalysts, technical indicators are bearish, and financial performance remains weak. Given the investor's profile and the absence of compelling reasons to invest immediately, holding off for now is recommended.
The MACD is positive but contracting, RSI is neutral at 29.274, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at S1: 1.993 and resistance at R1: 2.405. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news, hedge fund or insider activity, or congress trading data to suggest positive momentum.
The stock experienced a -5.26% regular market decline, and financial performance remains weak with no revenue and negative net income. Technical indicators are bearish, and there are no significant trading trends.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$3,387,118 (though improved by 62.53% YoY), and an EPS of -129.76 (up 201.07% YoY). Gross margin remains at 0%. Overall, the company is not showing strong financial health.
No recent analyst ratings or price target changes available.
